Conference Proceedings

Long-term safety and efficacy of natalizumab and assessment of 2-year freedom from clinical disease activity in patients with multiple sclerosis in the TYSABRI(R) observational programme

F Pellegrini, S Belachew, H Butzkueven, L Kappos, M Trojano, H Wiendl, A Zhang, R Arnold

MULTIPLE SCLEROSIS JOURNAL | SAGE PUBLICATIONS LTD | Published : 2012